HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Treatment of severe henoch-schonlein purpura nephritis with mycophenolate mofetil.

Abstract
Henoch-Schonlein purpura (HSP) is the most common childhood vasculitis. Renal involvement in HSP is one of the major causes of chronic renal failure in children. It is important to start effective and relatively safe medication to prevent end-stage renal disease (ESRD). Mycophenolate mofetil (MMF) appears to be a promising therapeutic agent in many autoimmune diseases such as lupus nephritis and vasculitis. Herein, we describe the treatment with MMF of three patients with HSP nephritis. In two cases with rapidly progressive glomerulonephritis without response to steroid, after treatment with MMF, significant improvement in kidney function and proteinuria were observed. In another patient with HSP nephritic-nephrotic syndrome who showed resistance to steroid, MMF offered a favorable effect. MMF seems to be a promising therapeutic agent in the treatment of the severe HSP nephritis.
AuthorsAhmad Ali Nikibakhsh, Hashem Mahmoodzadeh, Mohamad Karamyyar, Sasan Hejazi, Mehran Noroozi, Ali Agayar Macooie
JournalSaudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia (Saudi J Kidney Dis Transpl) Vol. 25 Issue 4 Pg. 858-63 (Jul 2014) ISSN: 1319-2442 [Print] Saudi Arabia
PMID24969202 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Steroids
  • mycophenolate mofetil
  • Mycophenolic Acid
Topics
  • Acute Kidney Injury (diagnosis, drug therapy, etiology)
  • Biopsy
  • Child
  • Child, Preschool
  • Drug Therapy, Combination
  • Female
  • Glomerulonephritis (diagnosis, drug therapy, etiology)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Male
  • Mycophenolic Acid (analogs & derivatives, therapeutic use)
  • Nephrotic Syndrome (diagnosis, drug therapy, etiology)
  • Purpura, Schoenlein-Henoch (complications, diagnosis, drug therapy)
  • Severity of Illness Index
  • Steroids (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: